Neonatal alloimmune neutropenia

disease
On this page

Summary

Neonatal alloimmune neutropenia (MONDO:0018739) is a disease. A subtype of neutropenia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Europe) [Orphanet-validated]
  • Phenotypes (HPO): 12

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Prevalence at birth1-5 / 10 00016.6PolandValidated

Signs & symptoms

Clinical features (HPO)

12 HPO clinical features (Orphanet curated; top 12 by frequency):

HPO IDTermFrequency
HP:0001904Neutropenia in presence of anti-neutropil antibodiesVery frequent (80-99%)
HP:0003453Antineutrophil antibody positivityVery frequent (80-99%)
HP:0002090PneumoniaFrequent (30-79%)
HP:0032169Severe infectionFrequent (30-79%)
HP:0000952JaundiceOccasional (5-29%)
HP:0001287MeningitisOccasional (5-29%)
HP:0001945FeverOccasional (5-29%)
HP:0005268Spontaneous abortionOccasional (5-29%)
HP:0005968Temperature instabilityOccasional (5-29%)
HP:0009800Maternal diabetesOccasional (5-29%)
HP:0032435Neonatal omphalitisOccasional (5-29%)
HP:0100806SepsisOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical nameneonatal alloimmune neutropenia
Mondo IDMONDO:0018739
Orphanet464370
SNOMED CT14333004
UMLSC0272176
MedGen543869
GARD0021929
Is cancer (heuristic)no

Disease family

This is a subtype of neutropenia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › immune system disorderleukocyte disorderleukopeniaagranulocytosisneutropenianeonatal alloimmune neutropenia

Related subtypes (3): transient neonatal neutropenia, constitutional neutropenia, ELANE-related neutropenia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.